Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Erectile Dysfunction × alpha-Tocopherol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Erectile Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

udenafil 1 mirabegron 1 bicalutamide 1 alpha-Tocopherol 1 Vitamin E 1 Tamoxifen 1 Tadalafil 1 Sildenafil Citrate 1 Pentoxifylline 1 Long-Term Synaptic Depression 1 GPI 1485 1 Erythropoietin 1 Dutasteride 1 Atorvastatin 1 Arginine 1 ArginMax 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed

14 enrolled 9 charts

Erectile Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡